title: The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
abstract: We recently reported that leukemic cells from IgVH-unmutated/progressive CLL more frequently proliferate in response to CpG-ODN stimulation than their corresponding counterparts. Here we evaluated the prognostic impact of this proliferative response in 91 CLL patients. The proliferative response was highly predictive of PFS, TTT and OS in the whole series and refined prognosis in patients with M-CLL. BCR stimulation modulated the response to CpG-ODN, suggesting that the proliferative capacity of the leukemic cells is related to antigen-encounter history. These data support the hypothesis that the capacity of the leukemic cells to respond to external stimuli influences disease progression in CLL.
authors.affiliation: Department of Haematology, Catholic University Hospital "A. Gemelli", Largo A. Gemelli, 8, 00168 Rome, Italy.
authors.forename: Michela
authors.initials: M
authors.lastname: Tarnani
authors.forename: Luca
authors.initials: L
authors.lastname: Laurenti
authors.forename: Pablo G
authors.initials: PG
authors.lastname: Longo
authors.forename: Nicola
authors.initials: N
authors.lastname: Piccirillo
authors.forename: Stefania
authors.initials: S
authors.lastname: Gobessi
authors.forename: Alice
authors.initials: A
authors.lastname: Mannocci
authors.forename: Sara
authors.initials: S
authors.lastname: Marietti
authors.forename: Simona
authors.initials: S
authors.lastname: Sica
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Leone
authors.forename: Dimitar G
authors.initials: DG
authors.lastname: Efremov
mesh_terms: D049109:Cell Proliferation; D018899:CpG Islands; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000473:pathology*; D008297:Male; D015999:Multivariate Analysis; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology*; D016019:Survival Analysis
chemical_list: D009838:Oligodeoxyribonucleotides